| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $52.0M | +42.5% |
| SG&A Expense | $25.1M | +14.9% |
| Operating Income | -$77.0M | -32.2% |
| Pre-tax Income | -$73.3M | -26.8% |
| Income Tax | -$9K | -139.1% |
| Net Income | -$73.3M | -26.7% |
| EPS (Basic) | -$1.61 | -25.8% |
| EPS (Diluted) | -$1.61 | -25.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.3M | -37.2% |
| Short-term Investments | $132.8M | +6.5% |
| Current Assets | $247.0M | -18.0% |
| Total Assets | $270.3M | -18.5% |
| Current Liabilities | $10.8M | -11.4% |
| Total Liabilities | $24.3M | +5.5% |
| Stockholders' Equity | $246.0M | -20.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.8M | -36.9% |
| Capital Expenditures | $8.0M | +491.8% |
| Investing Cash Flow | -$1.4M | +99.0% |
| Financing Cash Flow | $958K | -52.6% |
| Free Cash Flow | -$71.7M | -49.7% |